GODAVARI BIOREFINERIES L

Godavari Biorefineries Limited held its Q1 FY27 earnings conference call on August 7, 2026, where management discussed the company's financial performance and operational updates. Management reported a total income growth of 4.9% year-on-year, with the bio-based chemicals segment showing a significant revenue increase of 19.4% and EBITDA growth of 53%. The company successfully commissioned a new grain-based distillery, raising total capacity to 800 kilolitres per day. Management highlighted the importance of flexibility in feedstock to optimize production between sugar and ethanol based on market conditions. Challenges in the integrated sugar and ethanol segment were noted, with rising costs impacting profitability. Management also mentioned advancements in drug discovery, including a patent for a novel anticancer molecule and plans for preliminary efficacy trials. Overall, the company emphasized its commitment to sustainable growth and innovation in bio-based products.

The document presented both positive developments in revenue and challenges in profitability.